Arik A. Zur

911 total citations
12 papers, 716 citations indexed

About

Arik A. Zur is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Arik A. Zur has authored 12 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Arik A. Zur's work include Drug Transport and Resistance Mechanisms (5 papers), Amino Acid Enzymes and Metabolism (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Arik A. Zur is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Amino Acid Enzymes and Metabolism (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Arik A. Zur collaborates with scholars based in United States, Israel and Japan. Arik A. Zur's co-authors include Kathleen M. Giacomini, Kari M. Morrissey, Huan‐Chieh Chien, Matthias Wittwer, Sook Wah Yee, Xuexiang Zhang, Natalia Khuri, Andrej Săli, Yasuto Kido and Alan Kosaka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Journal of Pharmaceutical Sciences.

In The Last Decade

Arik A. Zur

12 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arik A. Zur United States	10	429	228	215	174	124	12	716
Eugene C. Chen United States	11	278 0.6×	225 1.0×	146 0.7×	94 0.5×	74 0.6×	14	617
Huan‐Chieh Chien United States	16	303 0.7×	391 1.7×	118 0.5×	219 1.3×	72 0.6×	22	809
Kinya Ohta Japan	17	344 0.8×	318 1.4×	231 1.1×	148 0.9×	44 0.4×	34	955
Masayuki Kakyo Japan	8	688 1.6×	180 0.8×	336 1.6×	156 0.9×	158 1.3×	11	954
Noriko Kohyama Japan	13	310 0.7×	204 0.9×	108 0.5×	65 0.4×	75 0.6×	34	628
Katja Damme Germany	6	366 0.9×	143 0.6×	197 0.9×	71 0.4×	87 0.7×	8	504
Masayuki Ohbayashi Japan	14	297 0.7×	224 1.0×	108 0.5×	65 0.4×	70 0.6×	34	664
Wataru Kishimoto Japan	15	449 1.0×	224 1.0×	197 0.9×	86 0.5×	431 3.5×	29	953
Jason A. Sprowl United States	19	747 1.7×	315 1.4×	295 1.4×	71 0.4×	151 1.2×	34	1.2k
Rie Nakagomi Japan	7	691 1.6×	152 0.7×	340 1.6×	102 0.6×	220 1.8×	7	874

Countries citing papers authored by Arik A. Zur

Since Specialization

Citations

This map shows the geographic impact of Arik A. Zur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arik A. Zur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arik A. Zur more than expected).

Fields of papers citing papers by Arik A. Zur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arik A. Zur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arik A. Zur. The network helps show where Arik A. Zur may publish in the future.

Co-authorship network of co-authors of Arik A. Zur

This figure shows the co-authorship network connecting the top 25 collaborators of Arik A. Zur. A scholar is included among the top collaborators of Arik A. Zur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arik A. Zur. Arik A. Zur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Zou, Ling, Pär Matsson, Adrian Stecuła, et al.. (2020). Drug Metabolites Potently Inhibit Renal Organic Anion Transporters, OAT1 and OAT3. Journal of Pharmaceutical Sciences. 110(1). 347–353. 17 indexed citations

Greenblatt, David J., et al.. (2020). The Effect of CYP3A Induction and Inhibition on the Pharmacokinetics of Laquinimod, a Novel Neuroimmunomodulator. Clinical Pharmacology in Drug Development. 9(8). 1015–1024. 3 indexed citations

Chu, Xiaoyan, Mingxiang Liao, Hong Shen, et al.. (2018). Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug‐Drug Interaction Evaluation: Perspectives From the International Transporter Consortium. Clinical Pharmacology & Therapeutics. 104(5). 836–864. 161 indexed citations

Zur, Arik A., et al.. (2018). The effect of laquinimod, a novel immuno-modulator in development to treat Huntington disease, on the pharmacokinetics of ethinylestradiol and levonorgestrel in healthy young women. European Journal of Clinical Pharmacology. 75(1). 41–49. 7 indexed citations

Chien, Huan‐Chieh, Claire Colas, Arik A. Zur, et al.. (2018). Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1). Journal of Medicinal Chemistry. 61(16). 7358–7373. 62 indexed citations

Khuri, Natalia, Arik A. Zur, Matthias Wittwer, et al.. (2017). Computational Discovery and Experimental Validation of Inhibitors of the Human Intestinal Transporter OATP2B1. Journal of Chemical Information and Modeling. 57(6). 1402–1413. 16 indexed citations

Zur, Arik A., Huan‐Chieh Chien, Lawrence Lin, et al.. (2016). LAT-1 activity of meta-substituted phenylalanine and tyrosine analogs. Bioorganic & Medicinal Chemistry Letters. 26(11). 2616–2621. 44 indexed citations

Zur, Arik A., Huan‐Chieh Chien, Andrew Flint, et al.. (2016). LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates. Bioorganic & Medicinal Chemistry Letters. 26(20). 5000–5006. 42 indexed citations

Zur, Arik A., Richard A. Castro, Matthias Wittwer, et al.. (2015). The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin. Clinical Pharmacokinetics. 55(6). 711–721. 48 indexed citations

10.

Chen, Ligong, Yan Shu, Xiaomin Liang, et al.. (2014). OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. Proceedings of the National Academy of Sciences. 111(27). 9983–9988. 182 indexed citations

11.

Wittwer, Matthias, Arik A. Zur, Natalia Khuri, et al.. (2012). Discovery of Potent, Selective Multidrug and Toxin Extrusion Transporter 1 (MATE1, SLC47A1) Inhibitors Through Prescription Drug Profiling and Computational Modeling. Journal of Medicinal Chemistry. 56(3). 781–795. 118 indexed citations

12.

Haroutiunian, Simon, Shimon Lecht, Arik A. Zur, Amnon Hoffman, & Elyad Davidson. (2009). The Challenge of Pain Management in Patients With Myasthenia Gravis. Journal of Pain & Palliative Care Pharmacotherapy. 23(3). 242–260. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact